Daniel Steinberg to Drug-Eluting Stents
This is a "connection" page, showing publications Daniel Steinberg has written about Drug-Eluting Stents.
Connection Strength
2.420
-
Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
Score: 0.380
-
Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
Score: 0.327
-
Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
Score: 0.301
-
Drug-eluting stent thrombosis. Minerva Cardioangiol. 2008 Feb; 56(1):127-37.
Score: 0.280
-
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
Score: 0.095
-
Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol. 2009 May; 21(5):210-4.
Score: 0.076
-
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
Score: 0.076
-
Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol. 2009 Feb 15; 103(4):496-500.
Score: 0.075
-
Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
Score: 0.075
-
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
Score: 0.075
-
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009 Mar 01; 103(5):653-8.
Score: 0.075
-
Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008 Dec 15; 102(12):1614-7.
Score: 0.073
-
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
Score: 0.072
-
Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008 Aug 01; 102(3):298-303.
Score: 0.072
-
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2008 Aug 01; 102(3):292-7.
Score: 0.072
-
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus. Am J Cardiol. 2008 May 01; 101(9):1253-8.
Score: 0.070
-
Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
Score: 0.070
-
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
Score: 0.069
-
Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007 Oct; 20(5):307-13.
Score: 0.068
-
Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
Score: 0.019